Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Systematic review and meta-analysis: the effects of fermented milk with Bifidobacterium lactis CNCM I-2494 and lactic acid bacteria on gastrointestinal discomfort in the general adult population.

Eales J, Gibson P, Whorwell P, Kellow J, Yellowlees A, Perry RH, Edwards M, King S, Wood H, Glanville J.

Therap Adv Gastroenterol. 2017 Jan;10(1):74-88. doi: 10.1177/1756283X16670075. Epub 2016 Oct 10. Review.

2.

Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis.

Cayzeele-Decherf A, Pélerin F, Leuillet S, Douillard B, Housez B, Cazaubiel M, Jacobson GK, Jüsten P, Desreumaux P.

World J Gastroenterol. 2017 Jan 14;23(2):336-344. doi: 10.3748/wjg.v23.i2.336.

3.

Can probiotics modulate human disease by impacting intestinal barrier function?

Bron PA, Kleerebezem M, Brummer RJ, Cani PD, Mercenier A, MacDonald TT, Garcia-Ródenas CL, Wells JM.

Br J Nutr. 2017 Jan;117(1):93-107. doi: 10.1017/S0007114516004037.

4.

Can probiotics benefit children with autism spectrum disorders?

Navarro F, Liu Y, Rhoads JM.

World J Gastroenterol. 2016 Dec 14;22(46):10093-10102. doi: 10.3748/wjg.v22.i46.10093. Review.

5.

Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.

Gallo A, Passaro G, Gasbarrini A, Landolfi R, Montalto M.

World J Gastroenterol. 2016 Aug 28;22(32):7186-202. doi: 10.3748/wjg.v22.i32.7186. Review.

6.

A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation.

Mezzasalma V, Manfrini E, Ferri E, Sandionigi A, La Ferla B, Schiano I, Michelotti A, Nobile V, Labra M, Di Gennaro P.

Biomed Res Int. 2016;2016:4740907. doi: 10.1155/2016/4740907. Epub 2016 Aug 9.

7.

Assessing worldwide research activity on probiotics in pediatrics using Scopus database: 1994-2014.

Sweileh WM, Shraim NY, Al-Jabi SW, Sawalha AF, Rahhal B, Khayyat RA, Zyoud SH.

World Allergy Organ J. 2016 Jul 25;9:25. doi: 10.1186/s40413-016-0116-1. eCollection 2016.

8.

The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments.

Farzaei MH, Bahramsoltani R, Abdollahi M, Rahimi R.

J Neurogastroenterol Motil. 2016 Oct 30;22(4):558-574. doi: 10.5056/jnm16001. Review.

9.

Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation.

Spiller R, Pélerin F, Cayzeele Decherf A, Maudet C, Housez B, Cazaubiel M, Jüsten P.

United European Gastroenterol J. 2016 Jun;4(3):353-62. doi: 10.1177/2050640615602571. Epub 2015 Aug 21. Erratum in: United European Gastroenterol J. 2017 Mar;5(2):304.

10.

Novel perspectives on therapeutic modulation of the gut microbiota.

McCarville JL, Caminero A, Verdu EF.

Therap Adv Gastroenterol. 2016 Jul;9(4):580-93. doi: 10.1177/1756283X16637819. Epub 2016 Apr 4. Review.

11.

Potential role of probiotics in the management of gastric ulcer.

Khoder G, Al-Menhali AA, Al-Yassir F, Karam SM.

Exp Ther Med. 2016 Jul;12(1):3-17. Epub 2016 Apr 26.

12.

Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis.

Zhang Y, Li L, Guo C, Mu D, Feng B, Zuo X, Li Y.

BMC Gastroenterol. 2016 Jun 13;16(1):62. doi: 10.1186/s12876-016-0470-z.

13.

Chronic Constipation and Constipation-Predominant IBS: Separate and Distinct Disorders or a Spectrum of Disease?

Siah KT, Wong RK, Whitehead WE.

Gastroenterol Hepatol (N Y). 2016 Mar;12(3):171-8.

14.

Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study.

Majeed M, Nagabhushanam K, Natarajan S, Sivakumar A, Ali F, Pande A, Majeed S, Karri SK.

Nutr J. 2016 Feb 27;15:21. doi: 10.1186/s12937-016-0140-6.

15.

Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Distrutti E, Monaldi L, Ricci P, Fiorucci S.

World J Gastroenterol. 2016 Feb 21;22(7):2219-41. doi: 10.3748/wjg.v22.i7.2219. Review.

16.

Part 2: Treatments for Chronic Gastrointestinal Disease and Gut Dysbiosis.

Bull MJ, Plummer NT.

Integr Med (Encinitas). 2015 Feb;14(1):25-33. Review.

17.

Vitamin D associates with improved quality of life in participants with irritable bowel syndrome: outcomes from a pilot trial.

Tazzyman S, Richards N, Trueman AR, Evans AL, Grant VA, Garaiova I, Plummer SF, Williams EA, Corfe BM.

BMJ Open Gastroenterol. 2015 Dec 21;2(1):e000052. doi: 10.1136/bmjgast-2015-000052. eCollection 2015.

18.

Irritable Bowel Syndrome: Peripheral Mechanisms and Therapeutic Implications.

Crişan IM, Dumitraşcu DL.

Clujul Med. 2014;87(2):73-9. doi: 10.15386/cjmed-269. Epub 2014 May 30. Review.

19.

Spatial Localization and Binding of the Probiotic Lactobacillus farciminis to the Rat Intestinal Mucosa: Influence of Chronic Stress.

Da Silva S, Robbe-Masselot C, Raymond A, Mercade-Loubière M, Salvador-Cartier C, Ringot B, Léonard R, Fourquaux I, Ait-Belgnaoui A, Loubière P, Théodorou V, Mercier-Bonin M.

PLoS One. 2015 Sep 14;10(9):e0136048. doi: 10.1371/journal.pone.0136048. eCollection 2015.

20.

Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It?

Mazurak N, Broelz E, Storr M, Enck P.

J Neurogastroenterol Motil. 2015 Oct 1;21(4):471-85. doi: 10.5056/jnm15071.

Supplemental Content

Support Center